MustGrow News Releases

Saskatoon, SK, December 5, 2019 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce it has increased the size of its previously-announced non-brokered private placement (the “Private Placement”). MustGrow is anticipating closing on an aggregate of 10,490,886 units for gross proceeds of C$3,671,810, scheduled to close on or about December 10, 2019.

Saskatoon, SK, November 15, 2019 – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (the "Company", "MustGrow"), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides, is pleased to announce a non-brokered private placement (the "Private Placement") of approximately 4,285,714 units (each a "Unit") for gross proceeds of up to approximately C$1,500,000 at a price per Unit of C$0.35.

Each Unit shall consist of one common share of the Company and one-half of one common share purchase warrant (each a "Warrant"). Each full Warrant shall entitle the holder to acquire one common share of the Company at a price of C$0.50 for a period of 24 months following the closing of the Private Placement.

  • National state of emergency declared in Colombia.
  • New soil-borne Fusarium pathogen is threatening the global supply of bananas.
  • Effective eradication is currently not possible, with Fusarium wilt TR4 remaining viable for decades in the soil.
  • MustGrow independent studies have confirmed 100% control of a similar soil-borne resilient Fusarium pathogen.